Where does Factor Bioscience Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Factor Bioscience Inc. ranks #5,585 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Factor Bioscience Inc. hold?

Factor Bioscience Inc. holds 61 US utility patents granted between 2015 and 2025, spanning 16 technology areas.

What is Factor Bioscience Inc.'s Innovation Score?

Factor Bioscience Inc. has an Innovation Score of 40.4 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Factor Bioscience Inc.'s patent grant rate increasing or decreasing?

Factor Bioscience Inc.'s recent grant velocity is +4% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Factor Bioscience Inc.'s patents?

Factor Bioscience Inc.'s patents average 13.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Factor Bioscience Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Factor Bioscience Inc.

Q: What technology areas does Factor Bioscience Inc. focus on?

Factor Bioscience Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 54 patents, ranking #186 of 4,144 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

USPTO PatentsView assignee record - 61 granted patents across 16 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Factor ranks #5,585 of 49,997 tracked US assignees by granted-patent volume, with 61 patents across 16 technology areas.

#5,585
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.4/100): 13.7
avg claims per patent: +4%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5585 · US Corporation #5,585 · 61 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 61 grants
UPPER-Q #5,585/49,997
PHOTO-FINISH Encore Medical
CPC-FOCUS C12N · 16 areas
INNOV-PAR 40.4/100
CLAIMS-RICH 13.7 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +4% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Encore Medical, LP (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Factor’s 40.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.3 pts (35%) Velocity 3.8 pts (9%) Breadth 14.1 pts (35%) Claim depth 8.2 pts (20%)

Qualcomm Incorporated · highest

85
Factor Bioscience · this assignee

40
Kyphon Sarl · near

40
Mbit Wireless · near

40
Thine · near

40
WisTa Laboratories · near

40
3D Lighting… · lowest

7

What this shows Factor's Innovation Score is 40.4/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Factor?

Each dot is one of Factor’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Factor’s own 13.7 claims/patent is at or below the 15.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Factor vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Factor's grants concentrate

Factor Bioscience Inc. is a focused PatentsView assignee: 16 CPC subclasses with 88.5% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2020 (12 grants) versus a trough of 1 in 2015. By volume, Factor sits between Encore Medical, LP and Gen Digital Inc..

Factor's three-year grant acceleration

From 2019–2021 to 2022–2024, Factor Bioscience Inc. moved from 23 to 13 grants (0.56x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Encore Medical

61
Entrust Datacard

61
Florida Power & L…

61
Fuji Electric FA…

61
Flooring

61
Garden Genetics

61
Groz-beckert KG

61
Gen Digital

61
Factor Bioscience ◀

61

What this shows Factor holds 61 patents at rank #5,586, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Factor

By rank, the assignees closest to #5,586 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Factor's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Factor, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Factor ranks #186 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Thine Electronics, Inc. 40 Mbit Wireless, Inc. 40 WisTa Laboratories Ltd. 40 Kyphon Sarl 40

Similar claim depth

Nearest assignees by average claims per patent (13.7 here).

Maxeon Solar Pte. Ltd. 13.7 avg West Pharma. Services IL, Ltd. 13.7 avg MPI Corporation 13.7 avg Deutsches Zentrum FÜR LUFT—UND Raumfahrt E.V. 13.7 avg

Factor's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Factor Bioscience Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	1.6%
2016	6	9.8%
2017	7	11.5%
2018	5	8.2%
2019	8	13.1%
2020	12	19.7%
2021	3	4.9%
2022	8	13.1%
2023	3	4.9%
2024	2	3.3%
2025partial year	6	9.8%

Which technologies does Factor Bioscience Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 54

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 53

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 50

C12Y - Enzymes 38

C07K - Peptides 27

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 18

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 12

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 12

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 12

H10F - Inorganic Semiconductor Devices Sensitive TO Infrared Radiation, Light, Electromagnetic Radiation OF Shorter Wavelength OR Corpuscular Radiation 12

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 12

C07C - Acyclic OR Carbocyclic Compounds 8

A61B - DIAGNOSIS; SURGERY; Identification 3

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 3

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 3

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Factor Bioscience Inc.'s patent record in context - here's where to go next.

Factor Bioscience Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 88.5% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #5,585 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Factor Bioscience Inc. against Encore Medical, LP, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.